Clinical Trials Directory

Trials / Completed

CompletedNCT02193035

Microparticles in Severe Aortic Stenosis

Microparticles as an Inflammatory Marker in Severe Aortic Stenosis.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
InCor Heart Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Microparticles are small cell fragments that can induce fat plaques, calcification and formation of thrombus. They can be released through multiple stimulations, but also the high flow of blood through partially obstructed aortic valves. In patients with severely obstructed aortic valves the investigators hypothesize that microparticles levels will be elevated and that they will go down after percutaneous treatment of the valves.

Detailed description

Microparticle (MPs) levels and subtypes according to endothelial cell, macrophage and platelet markers will be measured by flow-cytometry using appropriate fluorochromes. Patient baseline (including measures of severity of aortic stenosis and its calcification), procedural data, and clinical evolution will be collected. Inflammatory markers will be measured, which along with clinical date will be tested for correlation with microparticle levels. Patients MPs will be measured before and after percutaneous treatment of the severe aortic stenosis.

Conditions

Interventions

TypeNameDescription
OTHERMicroparticle levelsMicroparticle levels will be evaluated with flow cytometry and nanoparticle tracking analysis

Timeline

Start date
2014-06-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2014-07-17
Last updated
2016-04-13

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT02193035. Inclusion in this directory is not an endorsement.